These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 1981160

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors.
    Shen KF, Crain SM.
    Brain Res; 1990 Aug 20; 525(2):225-31. PubMed ID: 2174711
    [Abstract] [Full Text] [Related]

  • 3. Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential.
    Shen KF, Crain SM, Ledeen RW.
    Brain Res; 1991 Sep 13; 559(1):130-8. PubMed ID: 1685937
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside.
    Crain SM, Shen KF.
    Brain Res; 1992 Mar 13; 575(1):13-24. PubMed ID: 1324084
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures.
    Crain SM, Shen KF, Chalazonitis A.
    Brain Res; 1988 Jul 05; 455(1):99-109. PubMed ID: 2458169
    [Abstract] [Full Text] [Related]

  • 9. GM1 ganglioside-induced modulation of opioid receptor-mediated functions.
    Crain SM, Shen KF.
    Ann N Y Acad Sci; 1998 Jun 19; 845():106-25. PubMed ID: 9668346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell cultures.
    Chen GG, Chalazonitis A, Shen KF, Crain SM.
    Brain Res; 1988 Oct 18; 462(2):372-7. PubMed ID: 2847853
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic opioid treatment of neuroblastoma x dorsal root ganglion neuron hybrid F11 cells results in elevated GM1 ganglioside and cyclic adenosine monophosphate levels and onset of naloxone-evoked decreases in membrane K+ currents.
    Wu G, Fan SF, Lu ZH, Ledeen RW, Crain SM.
    J Neurosci Res; 1995 Nov 01; 42(4):493-503. PubMed ID: 8568936
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.
    Shen KF, Crain SM.
    Brain Res; 1995 Feb 27; 673(1):30-8. PubMed ID: 7757476
    [Abstract] [Full Text] [Related]

  • 18. Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.
    Wu G, Lu ZH, Alfinito P, Ledeen RW.
    Neurochem Res; 1997 Oct 27; 22(10):1281-9. PubMed ID: 9342733
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.